OCMMF
US OTC
Oncimmune Holdings plc
Overview
OCMMF
Symbol
US OTC
Exchange
About stock

Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a immunodiagnostic test for detecting and identifying lung cancer. The company also develops SeroTag, a platform that is used to discover and validate biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.

Oncimmune Holdings plc was incorporated in 2015 and is based in Nottingham, the United Kingdom.

Oncimmune Holdings plc dividend calculator
Report issue